Literature DB >> 13130349

[Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine]

Mirijam Fric1, Gerd Laux.   

Abstract

Elevations in prolactin plasma concentration occur with antipsychotics due to their dopamine D2 receptor antagonism. Hyperprolactinemia may be associated with both acute (galactorrhea, amenorrhea, decreased libido etc.) and chronic (predisposition to osteoporosis and cardiovascular disease) treatment emergent effects in both men and women associated with apparently impaired compliance. The aim of our study was to investigate these supposed effects regarding clinically relevant endocrinologic symptoms under routine treatment conditions with newer, atypical antipsychotics. Our findings confirm that amisulpride frequently leads to a remarkable elevation of prolactin plasma concentration, same - in minor degree - for risperidone. Under treatment with quetiapine and olanzapine just temporary elevated prolactin levels were registered. However, no correlation between prolactin levels and dosage could be found. In females treated with amisulpride acute hormonal side effects were seen in a clinically relevant manner. Features of illness itself, stress factors, concomitant medication or other patient's conditions are supposed to be relevant factors for acute endocrine symptomatology.

Entities:  

Year:  2003        PMID: 13130349     DOI: 10.1055/s-2003-39764

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  8 in total

1.  Quetiapine-induced galactorrhea with normal prolactin level in an adult female patient.

Authors:  Saira Mushtaq; Sadaf Khan; Harshad Patel
Journal:  Prim Care Companion CNS Disord       Date:  2012-04-19

Review 2.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  Kate McKeage; Greg L Plosker
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series.

Authors:  Sukhpreet Poonia; Mazen Sharaf; Ric M Procyshyn; Randal White; Reza Rafizadeh
Journal:  Can J Hosp Pharm       Date:  2022-07-04

Review 4.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

5.  Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.

Authors:  Qijing Bo; Fang Dong; Xianbin Li; Zhimin Wang; Xin Ma; Chuanyue Wang
Journal:  BMC Psychiatry       Date:  2016-11-09       Impact factor: 3.630

6.  Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study.

Authors:  Ping Yang; Liang Li; Dong Yang; Chaoying Wang; Hongli Peng; Huiyong Huang; Xuejun Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-26       Impact factor: 2.629

7.  Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.

Authors:  Thomas R E Barnes; Verity Leeson; Carol Paton; Louise Marston; David P Osborn; Raj Kumar; Patrick Keown; Rameez Zafar; Khalid Iqbal; Vineet Singh; Pavel Fridrich; Zachary Fitzgerald; Hemant Bagalkote; Peter M Haddad; Mariwan Husni; Tim Amos
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-08

8.  Hyperprolactinaemia with amisulpride.

Authors:  Rajnish Raj; Balwant Singh Sidhu
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.